The developer of the world's first FDA-cleared, smartphone-powered kidney test won in the Best in Class - Home Health Diagnostic...
DELRAY BEACH, Fla., Oct. 25, 2024 /PRNewswire/ -- The neuromorphic computing market is expected to grow from USD 28.5 million in 2024...
BOCA RATON, Fla., Oct. 25, 2024 /PRNewswire/ -- (OTCMKTS: VHAI) Vocodia, a leader in artificial intelligence and communication technologies, proudly...
AUSTIN, Texas, Oct. 25, 2024 /PRNewswire/ -- Lamar Consolidated Independent School District (LCISD) recently updated its security with a new hi-tech...
Vesalio Introduces pVasc™ U.S. clinical study initiative to capture real-world data and optimize results for patients suffering from peripheral vascular disease ...
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7%Net income of $57.8 million; Adjusted EBITDA of $302.5...
NEW YORK, NY / ACCESSWIRE / October 25, 2024 / Laxxon Medical Corp., a leading pharma technology company in oral...
Launches New Book, "Hair Pro Solutions: The Systematic Approach To Hair Styling & Financial Freedom" CINCINNATI, OH / ACCESSWIRE /...
Collaborative effort highlights the possibilities of integration of AI into radiology workflowNEWARK, DE / ACCESSWIRE / October 25, 2024 /...
Dr. Lewis Friedlander's clinical acumen surpasses artificial intelligence in a comparative study, highlighting the enduring importance of human experience in...
Titleist Performance Institute (TPI) is the world's leading educational organization for how the human body functions in relation to the...
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics...
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics...
Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline...
Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in...
HAMPTON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that 12 week results from the...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...
CHATHAM, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated...
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and...
Name Change Reflects Extensive Scientific and Corporate Brand Equity Previously Established under Grace Therapeutics Grace Therapeutics will begin trading on...